Day: March 6, 2025

Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

The Interim Analysis Showed Complete Clinical Clearance of More than Sixty (60%) PercentPhiladelphia, Pennsylvania--(Newsfile Corp. - March 6, 2025) -...

Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment...

Cosmo Pharmaceuticals Delivers Record 2024 Results – Completes Phase III Enrollment for Androgenetic Alopecia in Males – Proposes Increased Dividend of 2.05 per share – Reinforcing Shareholder Value and Growth Momentum into 2025

error: Content is protected !!